Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jul 28, 2010

Premium

London Genetics announced last week the appointment of two senior advisers, Stephen DeCherney and Munir Pirmohamed.

DeCherney, professor of medicine at the University of Carolina, was previously president of the Global Clinical Organization, and chief innovation officer at Quintiles Translational Corporation. Pirmohamed is the National Health Service chair of pharmacogenetics at the University of Liverpool and is involved in a warfarin pharmacogenetics study involving 2,000 patients, called EU-PACT Phase IV study.